PubMed:26937641 / 715-866
Annnotations
LitCoin-entities
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
11121 | 12-17 | GeneOrGeneProduct | denotes | NF-κB | NCBIGene:4790|NCBIGene:81736 |
11122 | 27-36 | DiseaseOrPhenotypicFeature | denotes | cytotoxic | MESH:D064420 |
11123 | 48-51 | GeneOrGeneProduct | denotes | SAA | NCBIGene:20208|NCBIGene:20210|NCBIGene:6288 |
11124 | 100-109 | GeneOrGeneProduct | denotes | caspase 3 | NCBIGene:25402|NCBIGene:836 |
11125 | 114-118 | GeneOrGeneProduct | denotes | PARP | NCBIGene:142|NCBIGene:25591 |
11126 | 132-141 | GeneOrGeneProduct | denotes | Annexin V | NCBIGene:25673|NCBIGene:308 |
LitCoin-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T7 | 0-151 | Sentence | denotes | Blockade of NF-κB revealed cytotoxic effects of SAA in primary HSCs with signs of apoptosis such as caspase 3 and PARP cleavage and Annexin V staining. |
LitCoin-GeneOrGeneProduct-v0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T31 | 48-51 | GeneOrGeneProduct | denotes | SAA |
T32 | 82-91 | GeneOrGeneProduct | denotes | apoptosis |
T33 | 100-109 | GeneOrGeneProduct | denotes | caspase 3 |
T34 | 114-118 | GeneOrGeneProduct | denotes | PARP |
T35 | 132-141 | GeneOrGeneProduct | denotes | Annexin V |
LitCoin-GeneOrGeneProduct-v2
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T19 | 48-51 | GeneOrGeneProduct | denotes | SAA |
T20 | 82-91 | GeneOrGeneProduct | denotes | apoptosis |
T21 | 100-109 | GeneOrGeneProduct | denotes | caspase 3 |
T22 | 114-118 | GeneOrGeneProduct | denotes | PARP |
T23 | 132-141 | GeneOrGeneProduct | denotes | Annexin V |
LitCoin-Disease-MeSH
Id | Subject | Object | Predicate | Lexical cue | originalLabel |
---|---|---|---|---|---|
T4 | 27-36 | DiseaseOrPhenotypicFeature | denotes | cytotoxic | DISEASE |
LitCoin-GeneOrGeneProduct-v3
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T13 | 48-51 | GeneOrGeneProduct | denotes | SAA |
T14 | 100-109 | GeneOrGeneProduct | denotes | caspase 3 |
T15 | 114-118 | GeneOrGeneProduct | denotes | PARP |
T16 | 132-141 | GeneOrGeneProduct | denotes | Annexin V |
LitCoin-MeSH-Disease-2
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T5 | 27-36 | DiseaseOrPhenotypicFeature | denotes | cytotoxic | DISEASE |
LitCoin-MONDO_bioort2019
Id | Subject | Object | Predicate | Lexical cue | #label |
---|---|---|---|---|---|
T2 | 27-36 | DiseaseOrPhenotypicFeature | denotes | cytotoxic | DISEASE |
LitCoin-training-merged
Id | Subject | Object | Predicate | Lexical cue | #label |
---|---|---|---|---|---|
T16 | 132-141 | GeneOrGeneProduct | denotes | Annexin V | |
T15 | 114-118 | GeneOrGeneProduct | denotes | PARP | |
T14 | 100-109 | GeneOrGeneProduct | denotes | caspase 3 | |
T13 | 48-51 | GeneOrGeneProduct | denotes | SAA | |
T57400 | 27-36 | DiseaseOrPhenotypicFeature | denotes | cytotoxic | DISEASE |
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T7 | 0-151 | Sentence | denotes | Blockade of NF-κB revealed cytotoxic effects of SAA in primary HSCs with signs of apoptosis such as caspase 3 and PARP cleavage and Annexin V staining. |
T7 | 0-151 | Sentence | denotes | Blockade of NF-κB revealed cytotoxic effects of SAA in primary HSCs with signs of apoptosis such as caspase 3 and PARP cleavage and Annexin V staining. |